Emerging countries "should pay more" for HIV/AIDS
The executive director of the Global Fund to Fight AIDS, Tuberculosis and Malaria, Michel Kazatchkine, has called on more emerging economies to follow the lead of Russia in contributing to the relief of HIV/AIDS. Speaking at the 17th International AIDS Conference which was held in Mexico City, Mr Kazatchkine, welcomed the decision of the Russian government to reimburse the full $300.0 million in aid it has received from the Global Fund.
However, the Financial Times reports that the Russian move may also be related to that government's unwillingness to comply with the Fund's standards for HIV/AIDS prevention, including needle exchanges for narcotic-injecting addicts who share syringes.
The Global Fund has received $6.0 billion in requests for new HIV/AIDS programs, while several countries have not kept up their previously-agreed payments.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
| Headless Content Management with Blaze